TG Therapeutics, Inc.
Key Metrics
Market Snapshot
About
TG Therapeutics is a biopharmaceutical company focused on developing and commercializing novel treatments for B-cell diseases, including chronic lymphocytic leukemia (CLL) and multiple sclerosis. The company markets BRIUMVI for relapsing forms of multiple sclerosis and continues advancing its pipeline of targeted immunotherapies.